
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e308-e319
Closed Access | Times Cited: 69
Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e308-e319
Closed Access | Times Cited: 69
Showing 1-25 of 69 citing articles:
Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort
Nathan D. Wong, Wenjun Fan, Xingdi Hu, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 16, pp. 1511-1525
Open Access | Times Cited: 18
Nathan D. Wong, Wenjun Fan, Xingdi Hu, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 16, pp. 1511-1525
Open Access | Times Cited: 18
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 16
Gissette Reyes‐Soffer, Calvin Yeang, Erin D. Michos, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100651-100651
Open Access | Times Cited: 16
Lipoprotein(a) and cardiovascular disease
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 16
Børge G. Nordestgaard, Anne Langsted
The Lancet (2024)
Closed Access | Times Cited: 16
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine
Julia Kenkre, Tina Mazaheri, R. Dermot G. Neely, et al.
Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2025)
Closed Access | Times Cited: 1
Julia Kenkre, Tina Mazaheri, R. Dermot G. Neely, et al.
Annals of Clinical Biochemistry International Journal of Laboratory Medicine (2025)
Closed Access | Times Cited: 1
Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk
Tarek Harb, Efthymios Ziogos, Roger S. Blumenthal, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 5
Tarek Harb, Efthymios Ziogos, Roger S. Blumenthal, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 5
The impact of tamoxifen on apolipoproteins and lipoprotein(a) levels: an updated meta-analysis of randomized controlled trials
Yi Jiang, Lantian Zhang, Dongyi Shen, et al.
Endocrine (2025)
Closed Access
Yi Jiang, Lantian Zhang, Dongyi Shen, et al.
Endocrine (2025)
Closed Access
Approach to Lipid Management in the Patient with Diabetes
Stephanie Kim, Savitha Subramanian
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Stephanie Kim, Savitha Subramanian
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
Hesham Sheashaa, Hana Mousa, Mohammed Tiseer Abbas, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 162-162
Open Access
Hesham Sheashaa, Hana Mousa, Mohammed Tiseer Abbas, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 162-162
Open Access
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Hayato Tada, Nobuko Kojima, Kan Yamagami, et al.
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 120-120
Open Access
Hayato Tada, Nobuko Kojima, Kan Yamagami, et al.
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 120-120
Open Access
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
Antonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Circulation (2025) Vol. 151, Iss. 6, pp. 400-415
Closed Access
Antonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Circulation (2025) Vol. 151, Iss. 6, pp. 400-415
Closed Access
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease
Megan Kalwick, Mendel Roth
Nutrients (2025) Vol. 17, Iss. 4, pp. 659-659
Open Access
Megan Kalwick, Mendel Roth
Nutrients (2025) Vol. 17, Iss. 4, pp. 659-659
Open Access
Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
Wann Jia Loh, Jing Pang, Oliver Simon, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Wann Jia Loh, Jing Pang, Oliver Simon, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Rethinking Cardiovascular Risk: The Emerging Role of Lipoprotein(a) Screening
Victoria Clair, Francis Zirille, Edward A. Gill
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100945-100945
Open Access
Victoria Clair, Francis Zirille, Edward A. Gill
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100945-100945
Open Access
Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays – Steps Toward Standardization
Alicia N. Lyle, Elias N Flores, Clark C Coffman, et al.
Journal of clinical lipidology (2025)
Closed Access
Alicia N. Lyle, Elias N Flores, Clark C Coffman, et al.
Journal of clinical lipidology (2025)
Closed Access
Current Clinical Trials for Treating Elevated Lipoprotein(a)
Christian David Vega Reyes, Rishi Rikhi, Sean Doherty, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Closed Access
Christian David Vega Reyes, Rishi Rikhi, Sean Doherty, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Closed Access
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Improving cholesterol management in high-risk primary prevention patients: an evidence-based case series
Tyler J. Schubert, Caroline deRichemond, Dean G. Karalis, et al.
Journal of clinical lipidology (2025)
Closed Access
Tyler J. Schubert, Caroline deRichemond, Dean G. Karalis, et al.
Journal of clinical lipidology (2025)
Closed Access
Lipoprotein(a) – From Biomarker to Therapy: A Review for the Clinician
Mawra Jha, Inbar R McCarthy, Eli V. Gelfand
The American Journal of Cardiology (2025)
Closed Access
Mawra Jha, Inbar R McCarthy, Eli V. Gelfand
The American Journal of Cardiology (2025)
Closed Access
Elevated Lipoprotein(a) Is Common in People With Familial Hypercholesterolemia and Negative Genetic Screening
Francis Gainsborough, Paul Welsh, Naveed Sattar, et al.
JACC Advances (2025) Vol. 4, Iss. 4, pp. 101648-101648
Closed Access
Francis Gainsborough, Paul Welsh, Naveed Sattar, et al.
JACC Advances (2025) Vol. 4, Iss. 4, pp. 101648-101648
Closed Access
Optimizing Long-term Cardiovascular Risk Stratification: Incorporating Biomarkers Into the Atherosclerotic Cardiovascular Disease Very High-Risk Definition
Jiaxi Cheng, Haoyu Wang, Chenxi Song, et al.
American Journal of Preventive Cardiology (2025), pp. 100965-100965
Open Access
Jiaxi Cheng, Haoyu Wang, Chenxi Song, et al.
American Journal of Preventive Cardiology (2025), pp. 100965-100965
Open Access
Impact of Sex Differences on Lipids and Statin Utilization
Carla Rodriguez, Semenawit Burka, Erin D. Michos
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Closed Access
Carla Rodriguez, Semenawit Burka, Erin D. Michos
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Closed Access
All we need to know about lipoprotein(a)
Courtney Bess, Anurag Mehta, Parag H. Joshi
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 4
Courtney Bess, Anurag Mehta, Parag H. Joshi
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 4
Early-onset atherosclerotic cardiovascular disease
Idine Mousavi, John Suffredini, Salim S. Virani, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 4
Idine Mousavi, John Suffredini, Salim S. Virani, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 4
Coronary Artery Calcium Scoring in the Context of Widespread Lipoprotein(a) Testing: Clinical Considerations and Implications for Lipid-Lowering Therapies
Srikanth Palanisamy, Semenawit Burka, Michael J. Blaha
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Srikanth Palanisamy, Semenawit Burka, Michael J. Blaha
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Helping clinicians interpret the evidence supporting dietary recommendations
Kevin C. Maki, P. Barton Duell
Journal of clinical lipidology (2025) Vol. 19, Iss. 1, pp. 1-2
Closed Access
Kevin C. Maki, P. Barton Duell
Journal of clinical lipidology (2025) Vol. 19, Iss. 1, pp. 1-2
Closed Access